FDA approves first nasal spray for dangerous allergic reactions
Health officials on Friday approved a nasal spray to treat severe allergic reactions, the first needle-free alternative to shots like EpiPen.
2024-08-12 20:15:52 - VI News Staff
The Food and Drug Administration (FDA) said it approved the spray from drugmaker ARS Pharmaceuticals Inc. as an emergency treatment for adults and older children experiencing life-threatening allergic reactions known as anaphylaxis.
Anaphylaxis is a severe, life-threatening allergic reaction. It can happen seconds or minutes after you’ve been exposed to something you’re allergic to. Peanuts or bee stings are examples. In anaphylaxis, the immune system releases a flood of chemicals that can cause the body to go into shock. Common symptoms include hives, swelling, itching, vomiting and difficulty breathing.